CLDN3 and endometrial cancer: Whereas the THESCs cells expressed barely detectable levels of CLDN-3 and -4 proteins, we observed dramatic overexpression of CLDN-3 in AN3-CA, EFE-184, MFE-280 and MFE-319 endometrial cancer cell lines relative to THESCs (Figure 1B).